ID

14533

Description

IFM 99-02 Thalidomide in Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00222053

Link

https://clinicaltrials.gov/show/NCT00222053

Keywords

Versions (1)
  1. 4/19/16 4/19/16 -
Uploaded on

April 19, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00222053

English

Eligibility Multiple Myeloma NCT00222053

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
de novo myeloma
Description

Myeloma

Data type

boolean

Alias
UMLS CUI [1]
C0026764
according to durie and salmon classification stage ii, iii and stage i with a lytic bone lesion
Description

Durie and salmon classification

Data type

boolean

Alias
UMLS CUI [1]
C0278722
UMLS CUI [2]
C02787223
UMLS CUI [3]
C0278724
patients from 18 to 65 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
beta2microglobulin < 3 mg/l or del13 absent
Description

Beta2microglobulin or del13

Data type

boolean

Alias
UMLS CUI [1]
C0201910
UMLS CUI [2]
C1517957
signed informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
eligible for transplantation
Description

Transplantation eligible

Data type

boolean

Alias
UMLS CUI [1,1]
C0040732
UMLS CUI [1,2]
C0013893
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
peripheral neurological toxicities
Description

Neurological toxicity

Data type

boolean

Alias
UMLS CUI [1]
C0031117
uncontrolled or severe cardiovascular disease
Description

Cardiovascular disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222
other malignancy except basocellular carcinoma or figo stage i carcinoma of the cervix
Description

Further malignancies

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C2216722
patient who received biphosphonate during the last 60 days
Description

Biphosphonate

Data type

boolean

Alias
UMLS CUI [1]
C0012544
renal failure definited as creatinine > 150 µmol/l
Description

Creatinine measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201976
patient with obvious vascular cerebral medical history
Description

Cerebrovascular disorder

Data type

boolean

Alias
UMLS CUI [1]
C0007820
liver dysfunction definited as bilirubin > 35 µmol/l or asat, alat, pal > 4n
Description

Bilirubin, asat, alat, pal

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C1278131
respiratory dysfunction
Description

Pulmonary function

Data type

boolean

Alias
UMLS CUI [1]
C0231921
hiv +
Description

HIV positivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
patient who refused to use an acceptable barrier method for contraception
Description

Contraception

Data type

boolean

Alias
UMLS CUI [1]
C0700589
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00222053

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Myeloma
Item
de novo myeloma
boolean
C0026764 (UMLS CUI [1])
Durie and salmon classification
Item
according to durie and salmon classification stage ii, iii and stage i with a lytic bone lesion
boolean
C0278722 (UMLS CUI [1])
C02787223 (UMLS CUI [2])
C0278724 (UMLS CUI [3])
Age
Item
patients from 18 to 65 years old
boolean
C0001779 (UMLS CUI [1])
Beta2microglobulin or del13
Item
beta2microglobulin < 3 mg/l or del13 absent
boolean
C0201910 (UMLS CUI [1])
C1517957 (UMLS CUI [2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Transplantation eligible
Item
eligible for transplantation
boolean
C0040732 (UMLS CUI [1,1])
C0013893 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Neurological toxicity
Item
peripheral neurological toxicities
boolean
C0031117 (UMLS CUI [1])
Cardiovascular disease
Item
uncontrolled or severe cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Further malignancies
Item
other malignancy except basocellular carcinoma or figo stage i carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
Biphosphonate
Item
patient who received biphosphonate during the last 60 days
boolean
C0012544 (UMLS CUI [1])
Creatinine measurement
Item
renal failure definited as creatinine > 150 µmol/l
boolean
C0201976 (UMLS CUI [1])
Cerebrovascular disorder
Item
patient with obvious vascular cerebral medical history
boolean
C0007820 (UMLS CUI [1])
Bilirubin, asat, alat, pal
Item
liver dysfunction definited as bilirubin > 35 µmol/l or asat, alat, pal > 4n
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1278131 (UMLS CUI [4])
Pulmonary function
Item
respiratory dysfunction
boolean
C0231921 (UMLS CUI [1])
HIV positivity
Item
hiv +
boolean
C0019699 (UMLS CUI [1])
Contraception
Item
patient who refused to use an acceptable barrier method for contraception
boolean
C0700589 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial